Kiniksa Pharmaceuticals Stock Price History

Below is the normalized historical share price chart for Kiniksa Pharmaceuticals extending back to May 24, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Kiniksa Pharmaceuticals stands at 21.80, as last reported on the 26th of November, with the highest price reaching 22.36 and the lowest price hitting 21.49 during the day. If you're considering investing in Kiniksa Stock, it is important to understand the factors that can impact its price. Kiniksa Pharmaceuticals has Sharpe Ratio of -0.0869, which conveys that the firm had a -0.0869% return per unit of risk over the last 3 months. Kiniksa Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Kiniksa Pharmaceuticals' Risk Adjusted Performance of (0.07), standard deviation of 2.89, and Mean Deviation of 1.96 to check out the risk estimate we provide. At present, Kiniksa Pharmaceuticals' Total Stockholder Equity is projected to decrease significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 552.6 M, whereas Common Stock Total Equity is forecasted to decline to about 13.4 K. . At present, Kiniksa Pharmaceuticals' Price Earnings Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Book Value Ratio is expected to grow to 2.94, whereas Price To Sales Ratio is forecasted to decline to 4.32. Kiniksa Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0869

Best Portfolio	Best Equity
Good Returns
Average Returns
Small Returns
Cash	Small Risk	Average Risk	High Risk	Huge Risk
Negative Returns		KNSA

Estimated Market Risk

Expected Return

Risk-Adjusted Return